Eco R1 Capital, LLC Cytom X Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$7.4 - $14.64 $8,147 - $16,118	-1,101 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.61 - $8.6 $1.48 Million - $3.52 Million	-408,899 Reduced 99.73%	1,101 $8,000
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $2.12 Million - $3.65 Million	410,000 New	410,000 $3.41 Million
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $15.8 Million - $19.2 Million	-829,771 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $11.2 Million - $15.1 Million	829,771	829,771 $15.1 Million

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.